Nutrition and bullous skin diseases

Ruocco, 1985, Pemphigus vulgaris in only one of two monozygotic twins, J Am Acad Dermatol, 12, 587, 10.1016/S0190-9622(85)80104-3 Brenner, 1994, Possible nutritional factors in induced pemphigus, Dermatology, 189, 337, 10.1159/000246874 Ruocco, 1996, A case of diet-related pemphigus, Dermatology, 192, 373, 10.1159/000246417 Chorzelski, 1996, Can pemphigus vulgaris be induced by nutritional factors?, Eur J Dermatol, 6, 284 Tur, 1997, The role of the water system as an exogenous factor in pemphigus, Int J Dermatol, 36, 810, 10.1046/j.1365-4362.1997.00350.x Tur, 1998, Diet and pemphigus. In pursuit of exogenous factors in pemphigus and fogo selvagem, Arch Dermatol, 134, 1406, 10.1001/archderm.134.11.1406 Brenner, 1998, Drug-induced pemphigus, Clin Dermatol, 16, 393, 10.1016/S0738-081X(98)00010-8 Brenner, 1995, Pemphigus and dietary factors. In vitro acantholysis by allyl compounds of the genus Allium, Dermatology, 190, 197, 10.1159/000246684 Lynfield, 1973, Pemphigus erythematosus provoked by allergic contact dermatitis. Occurence many years after thymoma removal, Arch Dermatol, 108, 690, 10.1001/archderm.108.5.690 Kaplan, 1993, Physically induced pemphigus after cosmetic procedures, Int J Dermatol, 32, 100, 10.1111/j.1365-4362.1993.tb01445.x Goldberg, 2001, A case of phenol-related contact pemphigus, Dermatology, 203, 355, 10.1159/000051793 Brenner, 2006, A possible mechanism for phenol-induced pemphigus, Skinmed, 5, 25, 10.1111/j.1540-9740.2006.04436.x Brenner, 2000, In vitro tannin acantholysis, Int J Dermatol, 39, 738, 10.1046/j.1365-4362.2000.00938.x Feliciani, 2007, Tannic acid induces in vitro acantholysis of keratinocytes via IL-1alpha and TNF-alpha, Int J Immunopathol Pharmacol, 20, 289, 10.1177/039463200702000209 Wittstock, 2007, Tipping the scales—specifier proteins in glucosinolate hydrolysis, IUBMB Life, 59, 744, 10.1080/15216540701736277 LE, 1964, Contact dermatitis from synthetic oil of mustard, Arch Dermatol, 90, 158, 10.1001/archderm.1964.01600020026004 Hirahashi, 2002, Activation of the human innate immune system by Spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis, Int Immunopharmacol, 2, 423, 10.1016/S1567-5769(01)00166-7 Lee, 2004, Activation of autoimmunity following use of immunostimulatory herbal supplements, Arch Dermatol, 140, 723, 10.1001/archderm.140.6.723 Kraigher, 2008, A mixed immunoblistering disorder exhibiting features of bullous pemphigoid and pemphigus foliaceus associated with Spirulina algae intake, Int J Dermatol, 47, 61, 10.1111/j.1365-4632.2007.03388.x Kumar, 1992, Serologic markers of gluten-sensitive enteropathy in bullous diseases, Arch Dermatol, 128, 1474, 10.1001/archderm.128.11.1474 Drago, 2005, Pemphigus improving with gluten-free diet, Acta Derm Venereol, 85, 84, 10.1080/00015550410022258 Atakan, 1993, Dyshidrosiform pemphigoid induced by nickel in the diet, Contact Dermatitis, 29, 159, 10.1111/j.1600-0536.1993.tb03520.x Economidou, 1998, Endomysium and antigliadin antibodies in dermatitis herpetiformis and other bullous diseases, J Eur Acad Dermatol Venereol, 11, 184, 10.1111/j.1468-3083.1998.tb00778.x Egan, 2001, Linear IgA bullous dermatosis responsive to a gluten-free diet, Am J Gastroenterol, 96, 1927, 10.1016/S0002-9270(01)02460-1 Leonard, 1982, Linear IgA disease in adults, Br J Dermatol, 107, 301, 10.1111/j.1365-2133.1982.tb00360.x Jablonska, 1979, IgA linear dermatosis (author's transl), Ann Dermatol Venereol, 106, 651 Leonard, 1987, Experience with a gluten free diet in the treatment of linear IgA disease, Acta Derm Venereol, 67, 145 Garioch, 1994, 25 years' experience of a gluten-free diet in the treatment of dermatitis herpetiformis, Br J Dermatol, 131, 541, 10.1111/j.1365-2133.1994.tb08557.x Mobacken, 1991, Gluten-free diet in clinical practice: a Scandinavian perspective, Clin Dermatol, 9, 415, 10.1016/0738-081X(91)90034-I Hall, 1987, Dietary management of dermatitis herpetiformis, Arch Dermatol, 123, 1378a, 10.1001/archderm.123.10.1378a Gawkrodger, 1984, Dermatitis herpetiformis: diagnosis, diet and demography, Gut, 25, 151, 10.1136/gut.25.2.151 Frodin, 1981, Gluten-free diet for dermatitis herpetiformis: the long-term effect on cutaneous, immunological and jejunal manifestations, Acta Derm Venereol, 61, 405, 10.2340/0001555561405411 Leonard, 1983, Gluten challenge in dermatitis herpetiformis, N Engl J Med, 308, 816, 10.1056/NEJM198304073081406 Nino, 2007, A long-term gluten-free diet as an alternative treatment in severe forms of dermatitis herpetiformis, J Dermatol Treat, 18, 10, 10.1080/09546630601123827 Leonard, 1983, Increased incidence of malignancy in dermatitis herpetiformis, Br Med J (Clin Res Ed), 286, 16, 10.1136/bmj.286.6358.16 Sigurgeirsson, 1994, Risk of lymphoma in patients with dermatitis herpetiformis, Bmj, 308, 13, 10.1136/bmj.308.6920.13 Askling, 2002, Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis, Gastroenterology, 123, 1428, 10.1053/gast.2002.36585 Collin, 1996, Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease, Gut, 38, 528, 10.1136/gut.38.4.528 Lewis, 1996, Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis, Br J Dermatol, 135, 363, 10.1111/j.1365-2133.1996.tb01496.x Hervonen, 2005, Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives, Br J Dermatol, 152, 82, 10.1111/j.1365-2133.2005.06345.x Reunala, 1998, Tolerance to oats in dermatitis herpetiformis, Gut, 43, 490, 10.1136/gut.43.4.490 Peraaho, 2004, Oats can diversify a gluten-free diet in celiac disease and dermatitis herpetiformis, J Am Diet Assoc, 104, 1148, 10.1016/j.jada.2004.04.025 Hardman, 1999, Absence of toxicity of avenin in patients with dermatitis herpetiformis, N Engl J Med, 340, 321, 10.1056/NEJM199901283400417 Hardman, 1997, Absence of toxicity of oats in patients with dermatitis herpetiformis, N Engl J Med, 337, 1884, 10.1056/NEJM199712253372604 Parnell, 1998, Absence of toxicity of oats in patients with dermatitis herpetiformis, N Engl J Med, 338, 1470, 10.1056/NEJM199805143382015 Gawkrodger, 1988, Nutritional status in patients with dermatitis herpetiformis, Am J Clin Nutr, 48, 355, 10.1093/ajcn/48.2.355 Hoffbrand, 1970, Malabsorption of dietary folate (Pteroylpolyglutamates) in adult coeliac disease and dermatitis herpetiformis, Br Med J, 4, 85, 10.1136/bmj.4.5727.85 Kastrup, 1986, Malabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anaemia, Acta Med Scand, 220, 261, 10.1111/j.0954-6820.1986.tb02761.x Menezes, 2006, Immunological activities are modulated by enteral administration of an elemental diet in mice, Clin Nutr, 25, 643, 10.1016/j.clnu.2006.01.005 Zeedijk, 1986, Dermatitis herpetiformis: consequences of elemental diet, Acta Derm Venereol, 66, 316 van der Meer, 1990, Gluten-free diet and elemental diet in dermatitis herpetiformis, Int J Dermatol, 29, 679, 10.1111/j.1365-4362.1990.tb03769.x Kadunce, 1991, The effect of an elemental diet with and without gluten on disease activity in dermatitis herpetiformis, J Invest Dermatol, 97, 175, 10.1111/1523-1747.ep12479517 Pock-Steen, 1970, Milk sensitivity in dermatitis herpetiformis, Br J Dermatol, 83, 614, 10.1111/j.1365-2133.1970.tb15755.x Engquist, 1971, Dermatitis herpetiformis and milk-free diet, Lancet, 2, 438, 10.1016/S0140-6736(71)90156-5 Shortridge, 1980, Milk, bread, and dermatitis herpetiformis, Lancet, 2, 587, 10.1016/S0140-6736(80)92018-8 From, 1974, Dermatitis herpetiformis. A case provoked by iodine, Br J Dermatol, 91, 221, 10.1111/j.1365-2133.1974.tb15869.x Charlesworth, 1976, Letter: Iodide-induced immunofluorescence in dermatitis herpetiformis, Arch Dermatol, 112, 555, 10.1001/archderm.112.4.555b Haffenden, 1980, The potassium iodide patch test in the dermatitis herpetiformis in relation to treatment with a gluten-free diet and dapsone, Br J Dermatol, 103, 313, 10.1111/j.1365-2133.1980.tb07250.x Salo, 1970, Papillary deposition of fibrin in iodide reactions in dermatitis herpetiformis, Ann Clin Res, 2, 19 Sciallis, 1976, Letter: Dermatitis herpetiformis and iodine, Br J Dermatol, 94, 343, 10.1111/j.1365-2133.1976.tb04395.x Douglas, 1975, Letter: Dermatitis herpetiformis, iodine compounds and thyrotoxicosis, Br J Dermatol, 92, 596, 10.1111/j.1365-2133.1975.tb03134.x Katz, 2009, Dermatitis herpetiformis flare associated with use of triiodomethane packing strips for alveolar osteitis, J Am Acad Dermatol, 60, 352, 10.1016/j.jaad.2008.08.041 Patinen, 2002, Iodine and gliadin challenge on oral mucosa in dermatitis herpetiformis, Acta Derm Venereol, 82, 86, 10.1080/00015550252948086 Juhlin, 1982, Blood glutathione-peroxidase levels in skin diseases: effect of selenium and vitamin E treatment, Acta Derm Venereol, 62, 211 Ljunghall, 1984, Selenium, glutathione-peroxidase and dermatitis herpetiformis, Acta Derm Venereol, 64, 546 Haynes, 2006, Nutritional support for children with epidermolysis bullosa, Br J Nurs, 15, 1097, 10.12968/bjon.2006.15.20.22292 Gruskay, 1988, Nutritional management in the child with epidermolysis bullosa, Arch Dermatol, 124, 760, 10.1001/archderm.124.5.760 Fine, 2008, Gastrointestinal complications of inherited epidermolysis bullosa: cumulative experience of the National Epidermolysis Bullosa Registry, J Pediatr Gastroenterol Nutr, 46, 147, 10.1097/MPG.0b013e31812f5667 Haynes, 1997, Constipation in epidermolysis bullosa: successful treatment with a liquid fiber-containing formula, Pediatr Dermatol, 14, 393, 10.1111/j.1525-1470.1997.tb00991.x Gamelli, 1988, Nutritional problems of the acute and chronic burn patient. Relevance to epidermolysis bullosa, Arch Dermatol, 124, 756, 10.1001/archderm.124.5.756 Birge, 1995, Nutrition management of patients with epidermolysis bullosa, J Am Diet Assoc, 95, 575, 10.1016/S0002-8223(95)00157-3 Lechner-Gruskay, 1988, Nutritional and metabolic profile of children with epidermolysis bullosa, Pediatr Dermatol, 5, 22, 10.1111/j.1525-1470.1988.tb00879.x Allman, 1992, Nutrition in dystrophic epidermolysis bullosa, Pediatr Dermatol, 9, 231, 10.1111/j.1525-1470.1992.tb00337.x Ingen-Housz-Oro, 2004, Vitamin and trace metal levels in recessive dystrophic epidermolysis bullosa, J Eur Acad Dermatol Venereol, 18, 649, 10.1111/j.1468-3083.2004.01067.x Fox, 2003, Are children with recessive dystrophic epidermolysis bullosa of low birthweight?, Pediatr Dermatol, 20, 303, 10.1046/j.1525-1470.2003.20404.x Fine, 1989, Blood vitamin and trace metal levels in epidermolysis bullosa, Arch Dermatol, 125, 374, 10.1001/archderm.125.3.374 Fridge, 1998, Correction of the anemia of epidermolysis bullosa with intravenous iron and erythropoietin, J Pediatr, 132, 871, 10.1016/S0022-3476(98)70321-X Atherton, 1999, Intravenous iron (III) hydroxide-sucrose complex for anaemia in epidermolysis bullosa, Br J Dermatol, 140, 773 Ackland, 2006, Zinc deficiency and its inherited disorders -a review, Genes Nutr, 1, 41, 10.1007/BF02829935 Melville, 1996, Fatal cardiomyopathy in dystrophic epidermolysis bullosa, Br J Dermatol, 135, 603, 10.1111/j.1365-2133.1996.tb03840.x Fewtrell, 2006, Bone mineralization in children with epidermolysis bullosa, Br J Dermatol, 154, 959, 10.1111/j.1365-2133.2005.07123.x Haynes, 1996, Gastrostomy and growth in dystrophic epidermolysis bullosa, Br J Dermatol, 134, 872, 10.1111/j.1365-2133.1996.tb06318.x Sehgal, 1972, Dystrophic epidermolysis bullosa in a family. Response to vitamin E (tocopherol), Dermatologica, 144, 27, 10.1159/000252092 Haber, 1985, Hereditary epidermolysis bullosa, J Am Acad Dermatol, 13, 252, 10.1016/S0190-9622(85)70168-5 Ayres, 1986, Epidermolysis bullosa controlled by vitamin E, Int J Dermatol, 25, 670, 10.1111/j.1365-4362.1986.tb04540.x Ayres, 1987, Epidermolysis bullosa responds to vitamin E when properly administered, J Am Acad Dermatol, 17, 848, 10.1016/S0190-9622(87)80285-2 Wilson, 1964, Treatment of epidermolysis bullosa dystrophica by alpha tocopherol, Can Med Assoc J, 90, 1315 Unger, 1973, Epidermolysis bullosa dystrophica treated with vitamin E and oral corticosteroids, Can Med Assoc J, 108, 1136 Smith, 1973, Vitamin E treatment of dermolytic bullous dermatosis: a controlled study, Arch Dermatol, 108, 254, 10.1001/archderm.108.2.254 Michaelson, 1974, treatment of epidermolysis bullosa. Changes in tissue collagenase levels, Arch Dermatol, 109, 67, 10.1001/archderm.109.1.67 Poblete-Gutierrez, 2006, The porphyrias: clinical presentation, diagnosis and treatment, Eur J Dermatol, 16, 230 Murphy, 1999, The cutaneous porphyrias: a review. The British Photodermatology Group, Br J Dermatol, 140, 573, 10.1046/j.1365-2133.1999.02754.x Sarkany, 2008, Making sense of the porphyrias, Photodermatol Photoimmunol Photomed, 24, 102, 10.1111/j.1600-0781.2008.00336.x Lim, 1999, The cutaneous porphyrias, Semin Cutan Med Surg, 18, 285, 10.1016/S1085-5629(99)80027-3 Elder, 1990, The cutaneous porphyrias, Semin Dermatol, 9, 63 Smith, 2000, Cutaneous manifestations of alcohol abuse, J Am Acad Dermatol, 43, 1, 10.1067/mjd.2000.104512 Cripps, 1987, Diet and alcohol effects on the manifestation of hepatic porphyrias, Fed Proc, 46, 1894 Kalivas, 1969, Phlebotomy and iron-overload in porphyria cutanea tarda, Lancet, 1, 1184, 10.1016/S0140-6736(69)92167-9 Drobacheff, 1998, Porphyria cutanea tarda associated with human immunodeficiency virus infection, Eur J Dermatol, 8, 492 Brady, 2000, Co-inheritance of mutations in the uroporphyrinogen decarboxylase and hemochromatosis genes accelerates the onset of porphyria cutanea tarda, J Invest Dermatol, 115, 868, 10.1046/j.1523-1747.2000.00148.x Doss, 2000, Alcohol and porphyrin metabolism, Alcohol Alcohol, 35, 109, 10.1093/alcalc/35.2.109 Elder, 1999, Alcohol intake and porphyria cutanea tarda, Clin Dermatol, 17, 431, 10.1016/S0738-081X(99)00029-2 De Matteis, 1998, Porphyria cutanea tarda of the toxic and sporadic varieties, Clin Dermatol, 16, 265, 10.1016/S0738-081X(97)00206-X Sampietro, 1999, Iron overload in porphyria cutanea tarda, Haematologica, 84, 248 Young, 2007, Porphyria cutanea tarda associated with Cys282Tyr mutation in HFE gene in hereditary hemochromatosis: a case report and review of the literature, Cutis, 80, 415 Kratka, 2008, High prevalence of HFE gene mutations in patients with porphyria cutanea tarda in the Czech Republic, Br J Dermatol, 159, 585, 10.1111/j.1365-2133.2008.08693.x Bulaj, 2000, Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda, Blood, 95, 1565, 10.1182/blood.V95.5.1565.005k42_1565_1571 Roberts, 1997, Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda, Lancet, 349, 321, 10.1016/S0140-6736(96)09436-6 Roberts, 1997, The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda, Hepatology, 25, 159, 10.1002/hep.510250129 Percy, 1975, Ascorbate status of patients with porphyria cutanea tarda symptomatica and its effect on porphyrin metabolism, S Afr J Med Sci, 40, 185 Sinclair, 1997, Ascorbic acid deficiency in porphyria cutanea tarda, J Lab Clin Med, 130, 197, 10.1016/S0022-2143(97)90096-2 Rocchi, 1995, Liposoluble vitamins and naturally occurring carotenoids in porphyria cutanea tarda, Eur J Clin Invest, 25, 510, 10.1111/j.1365-2362.1995.tb01737.x Gorman, 2007, Effect of iron and ascorbate on uroporphyria in ascorbate-requiring mice as a model for porphyria cutanea tarda, Hepatology, 45, 187, 10.1002/hep.21474 Pinelli, 2002, High-dose vitamin E lowers urine porphyrin levels in patients affected by porphyria cutanea tarda, Pharmacol Res, 45, 355, 10.1006/phrs.2002.0956 Anstey, 2002, Systemic photoprotection with alpha-tocopherol (vitamin E) and beta-carotene, Clin Exp Dermatol, 27, 170, 10.1046/j.1365-2230.2002.01040.x Watson, 1973, Lack of significant effect of vitamin E on porphyrin metabolism. Report of four patients with various forms of porphyria, Arch Intern Med, 131, 698, 10.1001/archinte.131.5.698 Mathews-Roth, 1993, Carotenoids in erythropoietic protoporphyria and other photosensitivity diseases, Ann N Y Acad Sci, 691, 127, 10.1111/j.1749-6632.1993.tb26164.x Dabrowska, 2001, Effect of high fiber vegetable-fruit diet on the activity of liver damage and serum iron level in porphyria cutanea tarda (PCT), Med Sci Monit, 7, 282 Thadani, 2000, Diagnosis and management of porphyria, Bmj, 320, 1647, 10.1136/bmj.320.7250.1647 Anderson, 2005, Recommendations for the diagnosis and treatment of the acute porphyrias, Ann Intern Med, 142, 439, 10.7326/0003-4819-142-6-200503150-00010 Frank, 1998, The genetic basis of “Scarsdale Gourmet Diet” variegate porphyria: a missense mutation in the protoporphyrinogen oxidase gene, Arch Dermatol Res, 290, 441, 10.1007/s004030050333 Romaguera, 2006, Nutritional assessment of patients affected by porphyria variegata, Ann Nutr Metab, 50, 442, 10.1159/000094719 Ferrer, 2010, Variegate porphyria induces plasma and neutrophil oxidative stress: effects of dietary supplementation with vitamins E and C, Br J Nutr, 103, 69, 10.1017/S0007114509991413 Elder, 1997, Hepatic porphyrias in children, J Inherit Metab Dis, 20, 237, 10.1023/A:1005313024076 Sassa, 2006, Modern diagnosis and management of the porphyrias, Br J Haematol, 135, 281, 10.1111/j.1365-2141.2006.06289.x Seip, 1974, Treatment of photosensitivity in congenital erythropoietic porphyria (CEP) with beta-carotene, Acta Derm Venereol, 54, 239 Mathews-Roth, 1998, Treatment of the cutaneous porphyrias, Clin Dermatol, 16, 295, 10.1016/S0738-081X(97)00208-3 Dawe, 2002, Congenital erythropoietic porphyria: dilemmas in present day management, Clin Exp Dermatol, 27, 680, 10.1046/j.1365-2230.2002.01166.x Fritsch, 1997, Congenital erythropoietic porphyria, J Am Acad Dermatol, 36, 594, 10.1016/S0190-9622(97)70249-4 Minder, 2009, A systematic review of treatment options for dermal photosensitivity in erythropoietic protoporphyria, Cell Mol Biol (Noisy-le-grand), 55, 84 Bayerl C. Beta-carotene in dermatology: Does it help? Acta Dermatovenerol Alp Panonica Adriat 2008;17:160-2, 4-6. Rhodes, 1998, Topical and systemic approaches for protection against solar radiation-induced skin damage, Clin Dermatol, 16, 75, 10.1016/S0738-081X(97)00171-5 Mathews-Roth, 1970, Beta-carotene as a photoprotective agent in erythropoietic protoporphyria, Trans Assoc Am Physicians, 83, 176 Mathews-Roth, 1974, Beta-carotene as an oral photoprotective agent in erythropoietic protoporphyria, Jama, 228, 1004, 10.1001/jama.228.8.1004 Mathews-Roth, 1977, Beta carotene therapy for erythropoietic protoporphyria and other photosensitivity diseases, Arch Dermatol, 113, 1229, 10.1001/archderm.113.9.1229 Krook, 1982, beta-Carotene in the treatment of erythropoietic protoporphyria. A short review, Acta Derm Venereol Suppl (Stockh), 100, 125 Corbett, 1977, The long term treatment with beta-carotene in erythropoietic protoporphyria: a controlled trial, Br J Dermatol, 97, 655, 10.1111/j.1365-2133.1977.tb14273.x Mathews-Roth, 2002, Long-term treatment of erythropoietic protoporphyria with cysteine, Photodermatol Photoimmunol Photomed, 18, 307, 10.1034/j.1600-0781.2002.02790.x Mathews-Roth, 1994, A double-blind study of cysteine photoprotection in erythropoietic protoporphyria, Photodermatol Photoimmunol Photomed, 10, 244 Roberts, 1993, Cysteine ameliorates photosensitivity in erythropoietic protoporphyria, Arch Dermatol, 129, 1350, 10.1001/archderm.129.10.1350 Bijlmer-Iest, 1992, Baart de la Faille H, van Asbeck BS, et al. Protoporphyrin photosensitivity cannot be attenuated by oral N-acetylcysteine, Photodermatol Photoimmunol Photomed, 9, 245 Sperl, 2009, N-acetyl cysteine averted liver transplantation in a patient with liver failure caused by erythropoietic protoporphyria, Liver Transpl, 15, 352, 10.1002/lt.21669 Bohm, 2001, Antioxidant inhibition of porphyrin-induced cellular phototoxicity, J Photochem Photobiol B, 65, 177, 10.1016/S1011-1344(01)00259-7 Boffa, 1996, A double-blind, placebo-controlled, crossover trial of oral vitamin C in erythropoietic protoporphyria, Photodermatol Photoimmunol Photomed, 12, 27, 10.1111/j.1600-0781.1996.tb00240.x Komatsu, 2000, A case of erythropoietic protoporphyria with liver cirrhosis suggesting a therapeutic value of supplementation with alpha-tocopherol, Hepatol Res, 18, 298, 10.1016/S1386-6346(00)00077-2 Ross, 1990, Relief of the photosensitivity of erythropoietic protoporphyria by pyridoxine, J Am Acad Dermatol, 22, 340, 10.1016/0190-9622(90)70043-H Rhodes, 1995, Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption, J Invest Dermatol, 105, 532, 10.1111/1523-1747.ep12323389 Rhodes, 1994, Dietary fish-oil supplementation in humans reduces UVB-erythemal sensitivity but increases epidermal lipid peroxidation, J Invest Dermatol, 103, 151, 10.1111/1523-1747.ep12392604 Pupe, 2002, Eicosapentaenoic acid, a n-3 polyunsaturated fatty acid differentially modulates TNF-alpha, IL-1alpha, IL-6 and PGE2 expression in UVB-irradiated human keratinocytes, J Invest Dermatol, 118, 692, 10.1046/j.1523-1747.2002.01615.x Chakrabarti, 2002, Dietary fish oils as a therapeutic option in erythropoietic protoporphyria, Clin Exp Dermatol, 27, 324, 10.1046/j.1365-2230.2002.10321.x Maverakis, 2007, Acrodermatitis enteropathica and an overview of zinc metabolism, J Am Acad Dermatol, 56, 116, 10.1016/j.jaad.2006.08.015 Jensen, 2008, Bullous lesions in acrodermatitis enteropathica delaying diagnosis of zinc deficiency: a report of two cases and review of the literature, J Cutan Pathol, 35, 1, 10.1111/j.1600-0560.2008.00981.x Lee, 2009, Bullous acrodermatitis enteropathica with interface dermatitis, J Cutan Pathol, 10.1111/j.1600-0560.2009.01382.x Maverakis, 2007, Acrodermatitis enteropathica, Dermatol Online J, 13, 11, 10.5070/D366V664N2 Sehgal, 2000, Acrodermatitis enteropathica, Clin Dermatol, 18, 745, 10.1016/S0738-081X(00)00150-4 Perafan-Riveros, 2002, Acrodermatitis enteropathica: case report and review of the literature, Pediatr Dermatol, 19, 426, 10.1046/j.1525-1470.2002.00200.x Borroni, 1992, Bullous lesions in acrodermatitis enteropathica. Histopathologic findings regarding two patients, Am J Dermatopathol, 14, 304, 10.1097/00000372-199208000-00003 Willis, 2005, Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination, Am J Clin Pathol, 123, 125, 10.1309/V6GVYW2QTYD5C5PJ Chandra, 1984, Excessive intake of zinc impairs immune responses, Jama, 252, 1443, 10.1001/jama.252.11.1443 van Beek, 2004, The glucagonoma syndrome and necrolytic migratory erythema: a clinical review, Eur J Endocrinol, 151, 531, 10.1530/eje.0.1510531 Mallinson, 1974, A glucagonoma syndrome, Lancet, 2, 1, 10.1016/S0140-6736(74)91343-9 Tierney, 2004, Etiology and pathogenesis of necrolytic migratory erythema: review of the literature, MedGenMed, 6, 4 Bloom, 1987, Glucagonoma syndrome, Am J Med, 82, 25, 10.1016/0002-9343(87)90424-4 Mullans, 1998, Iatrogenic necrolytic migratory erythema: a case report and review of nonglucagonoma-associated necrolytic migratory erythema, J Am Acad Dermatol, 38, 866, 10.1016/S0190-9622(98)70478-5 Hunt, 1991, Necrolytic migratory erythema: dyskeratotic dermatitis, a clue to early diagnosis, J Am Acad Dermatol, 24, 473, 10.1016/0190-9622(91)70076-E Stacpoole, 1981, The glucagonoma syndrome: clinical features, diagnosis, and treatment, Endocr Rev, 2, 347, 10.1210/edrv-2-3-347 Thorisdottir, 1994, Necrolytic migratory erythema: a report of three cases, J Am Acad Dermatol, 30, 324, 10.1016/S0190-9622(94)70033-8 Abraira, 1984, Disappearance of glucagonoma rash after surgical resection, but not during dietary normalization of serum amino acids, Am J Clin Nutr, 39, 351, 10.1093/ajcn/39.3.351 Blackford, 1991, Necrolytic migratory erythema without glucagonoma: the role of dietary essential fatty acids, Br J Dermatol, 125, 460, 10.1111/j.1365-2133.1991.tb14773.x Goodenberger, 1979, Necrolytic migratory erythema without glucagonoma, Arch Dermatol, 115, 1429, 10.1001/archderm.115.12.1429 Norton, 1979, Amino acid deficiency and the skin rash associated with glucagonoma, Ann Intern Med, 91, 213, 10.7326/0003-4819-91-2-213 Burton, 1993, Zinc and essential fatty acid therapy for necrolytic migratory erythema, Arch Dermatol, 129, 246, 10.1001/archderm.129.2.246 Shepherd, 1991, Treatment of necrolytic migratory erythema in glucagonoma syndrome, J Am Acad Dermatol, 25, 925, 10.1016/0190-9622(91)70285-A Alexander, 2002, Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome, Clin Endocrinol (Oxf), 57, 827, 10.1046/j.1365-2265.2002.01660.x Marinkovich, 1995, Necrolytic migratory erythema without glucagonoma in patients with liver disease, J Am Acad Dermatol, 32, 604, 10.1016/0190-9622(95)90345-3 Peterson, 1984, Glucagonoma syndrome: in vitro evidence that glucagon increases epidermal arachidonic acid, J Am Acad Dermatol, 11, 468, 10.1016/S0190-9622(84)70192-7 Doyle, 1979, Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis—possible pseudoglucagonoma syndrome, Br J Dermatol, 101, 581 Masri-Fridling, 1992, Necrolytic migratory erythema without glucagonoma, J Am Acad Dermatol, 27, 486, 10.1016/S0190-9622(08)80892-4 Karthikeyan, 2002, Pellagra and skin, Int J Dermatol, 41, 476, 10.1046/j.1365-4362.2002.01551.x Hegyi, 2004, Pellagra: dermatitis, dementia, and diarrhea, Int J Dermatol, 43, 1, 10.1111/j.1365-4632.2004.01959.x Ozturk, 2001, Pellagra: a sporadic pediatric case with a full triad of symptoms, Cutis, 68, 31 Delgado-Sanchez, 2008, Pellagra: rekindling of an old flame, Am J Ther, 15, 173, 10.1097/MJT.0b013e31815ae309 Prousky, 2003, Pellagra may be a rare secondary complication of anorexia nervosa: a systematic review of the literature, Altern Med Rev, 8, 180 Jagielska, 2007, Pellagra: a rare complication of anorexia nervosa, Eur Child Adolesc Psychiatry, 16, 417, 10.1007/s00787-007-0613-4 Isaac, 1998, The “gauntlet” of pellagra, Int J Dermatol, 37, 599, 10.1046/j.1365-4362.1998.00508.x